Phosphorylation of Ser711 residue in the HEV-3 HVR affects virus replication





Hepatitis E virus (HEV) is distinct from other hepatotropic viruses in that it is zoonotic and can infect across species barriers. HEV-1 and HEV-2 exclusively infect humans, whereas HEV-3 and HEV-4 are zoonotic infecting human and several other animal species. The viral and/or host factors responsible for HEV cross-species infection remain elusive. The hypervariable region (HVR) in HEV is extremely heterogenetic and has been implicated in HEV adaptation.

A recent study, led by Dr. Bo Wang and Prof. Xiang-Jin (“X.J.”) Meng from the Virginia Polytechnic Institute and State University, USA, investigated the potential role of serine phosphorylation in the HVR in HEV replication. They first analyzed HVR sequences across different genotypes of HEV and identified a unique region at the N-terminus of the HVR, which is variable in the human-exclusive HEV genotypes but relatively conserved in zoonotic HEV genotypes. They further identified four potential phosphorylation sites that are highly conserved in zoonotic HEV-3 and HEV-4 genomes but are absent in human-exclusive HEV-1 strains. To explore the functional significance of these putative phosphorylation sites, they introduced mutations into the HEV-3 infectious clone and indicator replicon, replacing each Serine residue individually with alanine or aspartic acid, and assessed the impact of these substitutions on HEV-3 replication. They found that the phospho-blatant S711A mutant significantly reduced HEV-3 replication, whereas the phospho-mimetic S711D mutant modestly reduced virus replication. However, mutations in the other three Serine residues did not significantly affect HEV-3 replication. Furthermore, they showed that Ser711 phosphorylation did not appear to alter host cell tropism of zoonotic HEV-3.

The findings from this study showed that potential phosphorylation of the Ser711 residue significantly affects HEV-3 replication in vitro, thus providing new insights into the potential mechanisms of zoonotic HEV transmission.

 

This study was published in mBio (October 2024) Pages e0263524. Read the full article

https://www.ncbi.nlm.nih.gov/pubmed/39377575.


Link Original Publication





More of this tag...

Virology

Discovery of HEV ORF2-derived fibrils reveals a new immune evasion mechanism
Published by Loan Dao Thi
The hepatitis E virus (HEV) capsid protein ORF2 is best known for its essential role in virion assembly. However, a new study by Jordan & Hu et al., led by Dr. Viet Loan Dao Thi, uncovers an unexpected second function of ORF2: the formation of in

Virology

G-Quadruplexes in HEV genome serve as antiviral targets
Published by Wenshi Wang
Hepatitis E virus (HEV) is a leading global cause of acute viral hepatitis, posing a severe threat to public health. The infection is especially dangerous for vulnerable populations: pregnant women face mortality rates of up to 25% due to acute liver






EVENTS

2025-01-18

International Joint Meeting on Viral Infections of the Liver and the Heart (2025)
Day two of this symposium will place a special emphasis on Hepatitis E — a virus that, despite being the most common cause of viral hepatitis, offers a valuable opportunity for further research and understanding. Venue: Cantinerie Berlin Gustav-Meyer-Allee 25 13355 Berlin, Germany. Organisers: Prof. Dr. Jens Kurreck, Dr. rer. nat. Daniel Todt, Prof. Dr. med. Heiner Wedemeyer, More information: Medizinische Hochschule Hannover : International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart (mhh.de)

GHEP offers free membership for your better connection with the hepatitis E community